From a scientific perspective, you need to keep in mind its a phase 2 trial and the results are good, but a phase 3 trial still has to be done for confirmation. Its not guaranteed.
From the clinicians point of view its a bit more exciting since its pretty hard to beat the VEGF-A treatments.
- Forums
- ASX - By Stock
- News: OPT Opthea Ltd Meets Primary Endpoint In Phase 2B Study Of Opt-302
From a scientific perspective, you need to keep in mind its a...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OPT (ASX) to my watchlist
(20min delay)
|
|||||
Last
90.5¢ |
Change
-0.010(1.09%) |
Mkt cap ! $1.114B |
Open | High | Low | Value | Volume |
91.5¢ | 91.8¢ | 89.5¢ | $1.036M | 1.140M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 31954 | 89.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
91.5¢ | 71302 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 31954 | 0.895 |
4 | 8312 | 0.890 |
3 | 61000 | 0.880 |
6 | 49472 | 0.870 |
3 | 27500 | 0.865 |
Price($) | Vol. | No. |
---|---|---|
0.915 | 71302 | 3 |
0.920 | 108396 | 8 |
0.925 | 28995 | 3 |
0.930 | 1075 | 1 |
0.940 | 42001 | 3 |
Last trade - 16.10pm 16/10/2024 (20 minute delay) ? |
Featured News
OPT (ASX) Chart |
The Watchlist
JBY
JAMES BAY MINERALS LIMITED
Andrew Dornan, Executive Director
Andrew Dornan
Executive Director
SPONSORED BY The Market Online